Fortress Biotech (FBIO) EBT (2010 - 2026)

Fortress Biotech's EBT history runs 16 years deep, the most recent figure standing at -$6.2 million for Q4 2025.

• In Q4 2025, EBT rose 76.08% year-over-year to -$6.2 million; the TTM figure through Dec 2025 stood at -$61.7 million (up 48.63% YoY), while the FY2025 annual figure was -$33.5 million, up 72.18% from the prior year.
• EBT for Q4 2025 stood at -$6.2 million, down from $8.9 million in the prior quarter.
• The five-year high for EBT was $8.9 million in Q3 2025, with the low at -$62.1 million in Q1 2023.
• The 5-year median for EBT is -$38.7 million (2024), against an average of -$37.2 million.
• The sharpest annual moves came in 2024 and 2025: EBT slumped 151.58% in 2024, then surged 133.25% in 2025.
• Fortress Biotech's EBT stood at -$59.4 million in 2021, then grew by 4.02% to -$57.0 million in 2022, then soared by 49.81% to -$28.6 million in 2023, then gained by 9.18% to -$26.0 million in 2024, then soared by 76.08% to -$6.2 million in 2025.
• Business Quant data shows FBIO's EBT at -$6.2 million in Q4 2025, $8.9 million in Q3 2025, and -$39.1 million in Q2 2025.